These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 20173500

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
    Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R.
    Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
    [Abstract] [Full Text] [Related]

  • 4. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [Abstract] [Full Text] [Related]

  • 5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [Abstract] [Full Text] [Related]

  • 6. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
    Staebler A, Sherman ME, Zaino RJ, Ronnett BM.
    Am J Surg Pathol; 2002 Aug; 26(8):998-1006. PubMed ID: 12170086
    [Abstract] [Full Text] [Related]

  • 7. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM.
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [Abstract] [Full Text] [Related]

  • 8. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
    Arfi A, Hequet D, Bataillon G, Tran-Perennou C, Farkhondeh F, Sastre-Garau X, Fourchotte V, Rouzier R, Laas E, Pouget N, Vincent-Salomon A, Jeannot E.
    BMC Cancer; 2019 Apr 23; 19(1):375. PubMed ID: 31014281
    [Abstract] [Full Text] [Related]

  • 9. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS, Beck AH, Longacre TA.
    Am J Surg Pathol; 2010 Jul 23; 34(7):915-26. PubMed ID: 20534993
    [Abstract] [Full Text] [Related]

  • 10. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin.
    Plunkett M, Brestovac B, Thompson J, Sterrett G, Filion P, Smith D, Frost F.
    Pathology; 2003 Oct 23; 35(5):397-401. PubMed ID: 14555383
    [Abstract] [Full Text] [Related]

  • 11. Human papillomavirus and mixed epithelial tumors of the endometrium.
    O'Leary JJ, Landers RJ, Crowley M, Healy I, O'Donovan M, Healy V, Kealy WF, Hogan J, Doyle CT.
    Hum Pathol; 1998 Apr 23; 29(4):383-9. PubMed ID: 9563789
    [Abstract] [Full Text] [Related]

  • 12. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct 23; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 13. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection.
    Chen R, Qin P, Luo Q, Yang W, Tan X, Cai T, Jiang Q, Chen H.
    Medicine (Baltimore); 2021 Apr 02; 100(13):e24927. PubMed ID: 33787580
    [Abstract] [Full Text] [Related]

  • 14. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
    Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ.
    Am J Surg Pathol; 2008 Dec 02; 32(12):1835-53. PubMed ID: 18813124
    [Abstract] [Full Text] [Related]

  • 15. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ, Ronnett BM.
    Am J Surg Pathol; 2005 Mar 02; 29(3):281-94. PubMed ID: 15725796
    [Abstract] [Full Text] [Related]

  • 16. Association of human papillomavirus with malignant and premalignant lesions of the uterine endometrium.
    Fujita M, Shroyer KR, Markham NE, Inoue M, Iwamoto S, Kyo S, Enomoto T.
    Hum Pathol; 1995 Jun 02; 26(6):650-8. PubMed ID: 7774896
    [Abstract] [Full Text] [Related]

  • 17. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS, Mashhour M, Noftech-Mozes S, Ismiil N, Dubé V, Ghorab Z, Faragalla H, Khalifa MA.
    Int J Gynecol Pathol; 2012 Jan 02; 31(1):57-65. PubMed ID: 22123724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.